Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Oncogene (11)
British Journal of Cancer (8)
Nature Medicine (2)
Nature Reviews Drug Discovery (1)
Nature (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (19)
Reviews (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Biotechnology
Cell biology
Chemical biology
Diseases
Health care
Materials science
Microbiology
Molecular biology
Oncology
Pathogenesis

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–23 of 23 results

Advanced filters: Author: A Insinga Clear advanced filters

A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

A Rocca
S Minucci
A Testori
ResearchOpen Access06 Jan 2009
British Journal of Cancer

Volume: 100, P: 28-36
Histone deacetylase inhibitors: molecular mechanisms of action

W S Xu
R B Parmigiani
P A Marks
Reviews13 Aug 2007
Oncogene

Volume: 26, P: 5541-5552
Pro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia

M I Tussié-Luna
L Rozo
A L Roy
Research23 Jan 2006
Oncogene

Volume: 25, P: 3375-3386
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma

A Trauzold
D Siegmund
H Wajant
Research05 Jun 2006
Oncogene

Volume: 25, P: 7434-7439
Erratum: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

A Insinga
S Monestiroli
P G Pelicci
Amendments and Corrections01 Feb 2005
Nature Medicine

Volume: 11, P: 233
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

Alessandra Insinga
Silvia Monestiroli
Pier Giuseppe Pelicci
Research26 Dec 2004
Nature Medicine

Volume: 11, P: 71-76
Atomically engineered interfaces yield extraordinary electrostriction

A system consisting of alternating thin films of two dielectrics is used to produce greatly enhanced electrostriction derived from coherent strain imparted by interfacial lattice discontinuity.

Haiwu Zhang
Nini Pryds
Vincenzo Esposito
Research21 Sept 2022
Nature

Volume: 609, P: 695-700
BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients

D D De Carvalho
R Binato
G P Amarante-Mendes
Research13 Sept 2010
Oncogene

Volume: 30, P: 223-233
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM

W Yin
A Rossin
H Gronemeyer
Research30 Jan 2006
Oncogene

Volume: 25, P: 3735-3744
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation

E Borbone
M T Berlingieri
A Fusco
Research05 Oct 2009
Oncogene

Volume: 29, P: 105-116
Discovery and development of SAHA as an anticancer agent

P A Marks
Reviews26 Feb 2007
Oncogene

Volume: 26, P: 1351-1356
Anticancer activities of histone deacetylase inhibitors

Johnstone and colleagues discuss the molecular events that underlie the anticancer effects of histone deacetylase inhibitors, and consider how the clinical development and application of these agents may be optimized, either as monotherapies or in combination with other anticancer drugs.

Jessica E. Bolden
Melissa J. Peart
Ricky W. Johnstone
Reviews01 Sept 2006
Nature Reviews Drug Discovery

Volume: 5, P: 769-784
Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women

N Muñoz
G Hernandez-Suarez
Á Muñoz
ResearchOpen Access17 Mar 2009
British Journal of Cancer

Volume: 100, P: 1184-1190
HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test

Nicole J Polman
Nienke J Veldhuijzen
Johannes Berkhof
ResearchOpen Access07 Sept 2017
British Journal of Cancer

Volume: 117, P: 1557-1561
Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53

G David
J-H Dannenberg
R A DePinho
Research12 Jun 2006
Oncogene

Volume: 25, P: 7354-7360
Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system

I H-I Chow
C-H Tang
R-F Pwu
ResearchOpen Access23 Nov 2010
British Journal of Cancer

Volume: 103, P: 1773-1782
FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

Roosmarijn Luttmer
Lise M A De Strooper
Chris J L M Meijer
ResearchOpen Access14 Jul 2016
British Journal of Cancer

Volume: 115, P: 579-587
Acetylation controls Notch3 stability and function in T-cell leukemia

R Palermo
S Checquolo
I Screpanti
Research28 Nov 2011
Oncogene

Volume: 31, P: 3807-3817
MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours

A Khandelwal
L K Gediya
V C O Njar
ResearchOpen Access18 Mar 2008
British Journal of Cancer

Volume: 98, P: 1234-1243
Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein

G Yang
M A Thompson
S W Hiebert
Research26 Jun 2006
Oncogene

Volume: 26, P: 91-101
TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt

E Szegezdi
S Cahill
A Samali
ResearchOpen Access24 Jan 2006
British Journal of Cancer

Volume: 94, P: 398-406
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

X Castellsagué
N Muñoz
A Saah
ResearchOpen Access31 May 2011
British Journal of Cancer

Volume: 105, P: 28-37
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells

P Grabarczyk
G K Przybylski
C A Schmidt
Research18 Dec 2006
Oncogene

Volume: 26, P: 3797-3810

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

Histone deacetylase inhibitors: molecular mechanisms of action

Pro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia

TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma

Erratum: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

Atomically engineered interfaces yield extraordinary electrostriction

BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients

Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM

Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation

Discovery and development of SAHA as an anticancer agent

Anticancer activities of histone deacetylase inhibitors

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test

Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53

Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

Acetylation controls Notch3 stability and function in T-cell leukemia

MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours

Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein

TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells

Search

Quick links